Fetal cells of mesenchymal origin in cultures derived from synovial tissue and skin of patients with rheumatoid arthritis

Joint Bone Spine

Volumn 75, Issue 5, 2008, Pages 563-566

  Hromadnikova, Ilona ^a   Zlacka, Denisa ^a   Hien Nguyen, Thi Thu ^a   Sedlackova, Lucie ^a   Zejskova, Lenka ^a   Sosna, Antonin ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Microchimerism; RA; Real time PCR

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; TESTIS DETERMINING FACTOR;

ADULT; AGED; ARTICLE; CARPAL BONE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FETUS CELL; GENE IDENTIFICATION; HIP; HUMAN; HUMAN CELL; HUMAN TISSUE; MARKER GENE; MESENCHYME CELL; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; MICROCHIMERISM; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SKIN CULTURE; SKIN FIBROBLAST; SYNOVECTOMY; SYNOVIUM;

ADULT; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHIMERISM; DNA; FEMALE; FETUS; FIBROBLASTS; GENETIC MARKERS; HUMANS; MALE; MESODERM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX-DETERMINING REGION Y PROTEIN; SKIN; SYNOVIAL MEMBRANE; YOUNG ADULT;

EID: 53149089071     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.02.004     Document Type: Article

References (39)

1. Artlett C.M. Pathophysiology of fetal microchimeric cells. Clin Chim Acta 360 (2005) 1-8
2. Fleta Asin B., Gonzalvo Liarte M.C., and Cia Gomez P. Chimerism: origin and medical implications. Rev Clin Esp 206 (2006) 340-342
3. Lapaire O., Hosli I., Zanetti-Daellenbach R., et al. Impact of fetal-maternal microchimerism on women's health - a review. J Matern Fetal Neonatal Med 20 (2007) 1-5
4. Yan Z., Lambert N.C., Guthrie K.A., et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 118 (2005) 899-906
5. Fast L.D. Microchimerism: a lasting legacy of transfusion?. Transfusion 46 (2006) 1856-1858
6. Teshima T., Matsuoka K., and Ichinohe T. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation. Arch Immunol Ther Exp (Warsz) 54 (2006) 165-172
7. Huu S.N., Dubernard G., Aractingi S., et al. Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells. Stem Cell Rev 2 (2006) 111-116
8. Bayes-Genis A., Bellosillo B., de la Calle O., et al. Identification of male cardiomyocytes of extracardiac origin in the hearts of women with male progeny: male fetal cell microchimerism of the heart. J Heart Lung Transplant 24 (2005) 2179-2183
9. Bianchi D.W., Zickwolf G.K., Weil G.J., et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad USA 93 (1996) 705-708
10. Guetta E., Gordon D., Simchen M.J., et al. Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis 30 (2003) 13-21
11. Campagnoli C., Roberts I.A., Kumar S., et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 (2001) 2396-2402
12. O' Donoghue K., Choolani M., Chan J., et al. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod 9 (2003) 497-502
13. Adams K.M., and Nelson J.L. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291 (2004) 1127-1131
14. Lambert N., and Nelson J.L. Microchimerism in autoimmune disease: more questions than answers?. Autoimmun Rev 2 (2003) 133-139
15. Khosrotehrani K., and Bianchi D.W. Multilineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 118 (2005) 1559-1563
16. Sawaya H.H., Jimenez S.A., and Artlett C.M. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis. Rheumatology 43 (2004) 965-968
17. Nelson J.L. Microchimerism and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 10 (1998) 564-571
18. Nelson J. Microchimerism and scleroderma. Curr Rheumatol Rep 1 (1999) 15-21
19. Artlett C.M., Smith J.B., and Jimenez S.A. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 338 (1998) 1186-1191
20. Ohtsuka T., Miyamoto Y., Yamakage A., et al. Quantitative analysis of microchimerism in systemic sclerosis skin tissue. Arch Dermatol Res 293 (2001) 387-391
21. Johnson K.L., Nelson J.L., Furst D.E., et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 44 (2001) 1848-1854
22. Renne C., Ramos Lopez E., Steimle-Grauer S.A., et al. Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J Clin Endocrinol 89 (2004) 5810-5814
23. Klintschar M., Immel U.D., Kehlen A., et al. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol 154 (2006) 237-241
24. Hartzheim L.A., and Goss G.L. Rheumatoid arthritis: a case study. Nurs Clin North Am 33 (1998) 595-602
25. Abdel-Nasser A.M., Rasker J.J., and Valkenburg H.A. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum 27 (1997) 123-140
26. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
27. Lo Y.M., Corberra N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350 (1997) 485-487
28. Lo Y.M., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive prenatal diagnosis. Am J Hum Genet 62 (1998) 768-775
29. Bessis N., Lemeiter D., Laroche L., et al. Joint Bone Spine 74 (2007) 48-51
30. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2 (1974) 83-92
31. Owen M., and Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136 (1988) 42-60
32. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
33. Jones E.A., English A., Henshaw K., et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 50 (2004) 817-827
34. Evans P.C., Lambert N., Maloney S., et al. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 93 (1999) 2033-2037
35. Lambert N.C., Lo Y.M., Erickson T.D., et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 100 (2002) 2845-2851
36. Filer A., Parsonage G., Smith E., et al. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum 54 (2006) 2096-2108
37. Hayashida K., Shimaoka Y., Ochi T., et al. Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol 164 (2000) 1110-1116
38. Burger J.A., Zvaifler N.J., Tsukada N., et al. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1 and CD106 (VCAM-1)-dependent mechanism. J Clin Invest 107 (2001) 305-315
39. Ohata J., Zvaifler N.J., Nishio M., et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 174 (2005) 864-870